湖北华博医药科技有限公司

Hubei Huabo Pharmatech Co., Ltd.

        Huabo Pharma was established on March 7, 2022. It is located in Saifu Industrial Park of Changjiangbu, Yingcheng, Hubei, （a provincial-level chemical Area）.

        Huabo Pharma covers land area of 90000 square meters with planned total investment 300 million RMB, and it is specialized in production of APIs and intermediates including Ribavirin , Gliptins series, Tatins series and Sartans series etc.   Huahbo Pharma was generously supported by local government and listed as Yingcheng key investment promotion project in 2023. Huabo’s main management team are from Zhejiang listed big pharmaceutical companies.  

        Huabo Pharma acquired Hubei Zhicheng Chemical Co., Ltd in Sep 2022.   Hubei Zhicheng Chemical was established on 19 Nov 2002 and was credited as High-Tech enterprise. Hubei Zhicheng is the largest manufacturer of 1H-1,2,4-Triazole-5-carboxylic acid methyl ester in China and Zhicheng Chem has obtained certification of ISO 9001 and was credited as Provincial “Little Giant" firm in 2019.

        Hubei Huabo Pharma and Hubei Zhicheng Chem have established long term stable business with some famous pharmaceutical companies home and abroad.

        Our core value: Quality, Innovation, reliability and sustainability

        Our business concept:  Customer centric and Market driven.